This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

Menu
Register
keyboard_arrow_right

Day 3 - January 13 - PST/PDT (Pacific Daylight, GMT-7)

keyboard_arrow_leftSearch & Filter
search

Day 3 - January 13 - PST/PDT (Pacific Daylight, GMT-7)

search
Session content is available on-demand in partneringONE until March 31
8:00am - 7:00am1380 mins
One-to-one meetings
Partnering: One-to-one meetings
    8:30am - 9:45am75 mins
    Rare Beyond the Square
    LIVE SESSION - Leveraging platform approaches to gene therapies to accelerate therapeutic development for monogenic diseases
    • Allyson Berent - CSO and COO, Foundation for Angelman Syndrome Therapeutics, GeneTx Biotherapeutics
    • P.J. Brooks - Program Director, Office of Rare Diseases Research, National Center for Advancing Translational Sciences (NCATS), NIH
    • Nicole Guadelli - Director and Head of Gene Editing Technologies, Beam Therapeutics
    • Nick Leschly - Chief Bluebird, bluebird bio
    • Peter Marks - Director of Center for Biologics Evaluation and Research, U.S. Food and Drug Administration
    12:00pm - 12:20pm20 mins
    Biotech Showcase
    LIVE SESSION: Alliance for Regenerative Medicine’s annual cell & gene state of the industry briefing
    • Janet Lambert - CEO, Alliance for Regenerative Medicine
    12:20pm - 1:00pm40 mins
    Biotech Showcase
    LIVE SESSION: Looking Ahead – What to expect for the cell & gene therapy sector in 2021 and beyond
    • Janet Lambert - CEO, Alliance for Regenerative Medicine
    • Terry-Ann Burrell - CFO, Beam Therapeutics
    • Marianne De Backer - Executive VP, Head of Strategy, Business Development & Licensing and Executive Committee Member, Bayer AG, Pharmaceuticals
    • Sandy Macrae - President & CEO, Sangamo Therapeutics
    • Ken Mills - President and CEO, REGENXBIO
    • Adrian Rawcliffe - CEO, Adaptimmune
    2:00pm - 3:30pm90 mins
    Seed Showcase
    LIVE SESSION with Interactive Networking: Seed Financing: Value Creation - Laying the foundation to raise money
    • Ben Johnson - Head of Early Stage Life Science, Silicon Valley Bank
    • Stephen Flaim - Senior Special Advisor and Investor-in-Residence, National Institutes of Health
    • Beth Hoffman - Founder and CEO, Origami Therapeutics, Inc.
    • Tomas Landh - Innovation Sourcing VP, Senior Principal Scientist, Novo Nordisk
    • Jon Layman - Partner, Hogan Lovells
    • Una S. Ryan - Managing Director, Golden Seeds
    Day 2 - January 12
    NextDay 4 - January 14
    Filter
    Streams
    Formats
    Choose Day